Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 13, 2026
Amcor (AMCR) Delivers Solid Earnings Beat with Berry Global Integration Ahead of Plan

Amcor (AMCR) Delivers Solid Earnings Beat with Berry Global Integration Ahead of Plan

Key Takeaways

  • Amcor reported fiscal fourth-quarter 2026 adjusted earnings per share (EPS) of $1.23, above the $1.19 analyst consensus, while full-year adjusted EPS rose 13% to $4.02.
  • Net sales increased 26% year over year to $6.4 billion, ahead of the $6.05 billion consensus, supported by the Berry Global acquisition and higher raw-material pass-through.
  • Berry integration synergies reached $115 million in the quarter and $285 million for fiscal 2026, roughly 10% above the company’s initial first-year target.
  • Fiscal 2026 free cash flow came in at $1.3 billion, below guidance, as inventory held to protect customer supply during the Middle East conflict weighed on working capital.
  • Amcor introduced adjusted EPS guidance of $1.80 to $1.90 for the six-month transition period ending December 31, 2026, as it shifts to a calendar-aligned fiscal year.
  • The board declared a quarterly dividend of $0.65 per share, up from $0.6375.

Earnings Context and Why It Matters

This was Amcor’s final report under its June 30 fiscal year and the first full fiscal year since completing its all-stock combination with Berry Global on April 30, 2025. Investors were focused on whether the packaging leader could sustain margin expansion, confirm a volume inflection, and convert Berry synergies into earnings. The quarterly earnings release also served as a bridge to a new reporting structure, with Amcor moving its fiscal year-end to December 31. The results matter beyond a single quarter because they indicate whether the combined company can manage input-cost inflation, protect free cash flow, and maintain investment-grade credit metrics while integrating a transformative acquisition. To put the numbers in broader context, I also checked this using Tickeron’s AI Screener to see how Amcor compares with peers in the packaging sector.

Reported Results

For the quarter ended June 30, 2026, Amcor reported adjusted diluted EPS of $1.23, up 23% year over year and $0.04 above the $1.19 consensus. Net sales rose 26% to $6.4 billion from $5.1 billion, exceeding the $6.05 billion consensus. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) increased 32% to $1.045 billion, while adjusted EBIT (earnings before interest and taxes) reached $836 million.

Net income was $389 million, reversing a $39 million prior-year loss. GAAP (generally accepted accounting principles) diluted EPS was $0.83, compared with a $0.10 loss a year earlier. Comparable volumes rose about 0.5% excluding non-core and divested operations, a sequential improvement of roughly 200 basis points. Segment margins expanded, with adjusted EBIT margins of 15.1% in flexible packaging and 12.3% in rigid packaging.

Fiscal 2026 free cash flow totaled $1.3 billion, below guidance, while adjusted free cash flow reached $1.593 billion before roughly $290 million of Berry transaction, restructuring, and integration costs. Net debt stood at $12.897 billion, with leverage of 3.5 times, in line with expectations. Amcor expects to recover more than $500 million of working-capital and integration-related cash flow over the next 12 months.

Market Reaction and Investor Sentiment

The stock delivered a muted response to an otherwise strong earnings beat. Amcor shares edged about 0.9% lower in premarket trading on August 12, 2026, and closed down 1.77% at $46.56, according to market data. Investors appeared to focus less on the EPS and revenue beats and more on the free cash flow shortfall, elevated inventory, and the transition-period guidance. The reaction suggests that sentiment is being shaped by balance-sheet and cash-conversion concerns rather than operating momentum, even as management pointed to improving volumes and faster-than-planned synergy capture.

Forward Outlook and Key Factors to Monitor

Amcor’s near-term focus is its transition period. For the six months ending December 31, 2026, the company guided to adjusted EPS of $1.80 to $1.90, with a midpoint of $1.85. For the September 2026 quarter, it projected adjusted EPS of approximately $0.92 to $0.98. Management expects leverage of 3.5 to 3.6 times by December 31, 2026, and continues to target roughly 3.0 times by the end of calendar 2027.

Cash flow recovery will be a central monitor. Amcor expects to recover more than $500 million over the next 12 months as Middle East-related working capital effects and integration costs unwind. Investors will also track whether the modest volume inflection continues across food service, pet care, and protein categories, and whether weakness in lower-margin healthcare categories stabilizes.

Looking further ahead, management has framed calendar 2027 as the first “clean” year for the combined company, with double-digit adjusted EPS growth targeted and the majority of the $650 million synergy program expected to be realized. Key factors include raw-material and resin cost trends, pricing actions, divestiture execution, and the pace of debt reduction.

Enhancing My Research with Tickeron Tools

In my own workflow I regularly use Tickeron’s AI Screener to scan for patterns and fundamentals across the packaging space. It helps me quickly compare metrics like margins, volume trends, and peer performance without spending hours on manual screens. This has become a useful complement when evaluating names like Amcor after earnings releases.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMCR

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Aroon Indicator for AMCR shows an upward move is likely

AMCR's Aroon Indicator triggered a bullish signal on August 12, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 196 similar instances where the Aroon Indicator showed a similar pattern. In of the 196 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 24, 2026. You may want to consider a long position or call options on AMCR as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMCR just turned positive on July 28, 2026. Looking at past instances where AMCR's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for AMCR moved above the 200-day moving average on July 29, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMCR advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AMCR moved out of overbought territory on July 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AMCR broke above its upper Bollinger Band on July 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.817) is normal, around the industry mean (6.700). P/E Ratio (19.487) is within average values for comparable stocks, (29.067). Projected Growth (PEG Ratio) (0.632) is also within normal values, averaging (0.960). AMCR has a moderately high Dividend Yield (0.056) as compared to the industry average of (0.031). P/S Ratio (0.915) is also within normal values, averaging (1.295).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Industry description

The containers/packing sector includes companies that manufacture containers (like plastic and aluminum food containers, glass bottles, metal cans, cardboard, storage and waste bags, giftwraps etc.) and provide packing services. Food-and-beverage and household products are major markets for this business. Several companies in this industry cater to international markets in addition to serving domestic customers. Consumer spending habits could potentially affect this industry’s performance. Some products, that use oil-based materials as inputs, are likely to see their costs of production get impacted (to some extent) by energy price movements. The ever-expanding e-commerce market has only supercharged the amount/frequency of goods shipped domestically and across borders, thereby creating ample potential opportunities for containers and packaging businesses. Ball Corporation, International Paper Company, Amcor Plc and Packaging Corporation of America are some of the largest U.S. companies in this industry.

Market Cap

The average market capitalization across the Containers/Packaging Industry is 7.61B. The market cap for tickers in the group ranges from 6.74K to 66.8B. STO holds the highest valuation in this group at 66.8B. The lowest valued company is EPTI at 6.74K.

High and low price notable news

The average weekly price growth across all stocks in the Containers/Packaging Industry was 2%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 2%. ORBS experienced the highest price growth at 13%, while MYE experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Containers/Packaging Industry was -6%. For the same stocks of the Industry, the average monthly volume growth was -8% and the average quarterly volume growth was -11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 57
Price Growth Rating: 50
SMR Rating: 71
Profit Risk Rating: 82
Seasonality Score: -34 (-100 ... +100)
View a ticker or compare two or three
AMCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in the provision of consumer packaging business.

Industry ContainersPackaging

Profile
Details
Industry
N/A
Address
83 Tower Road North
Phone
+44 1179753200
Employees
41000
Web
https://www.amcor.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.